Global Over The Counter (OTC) Testing Market to Reach $39 Billion by 2030
The global market for Over The Counter (OTC) Testing estimated at US$19.4 Billion in the year 2022, is projected to reach a revised size of US$39 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2022-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$10.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pregnancy & Fertility Tests segment is readjusted to a revised 9.5% CAGR for the next 8-year period.The U.S. Market is Estimated at $5.7 Billion, While China is Forecast to Grow at 8.7% CAGR
The Over The Counter (OTC) Testing market in the U.S. is estimated at US$5.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.Select Competitors (Total 33 Featured) -
- Abbott Laboratories
- AccuBioTech
- ACON Laboratories
- bioLytical Laboratories
- i-Health Lab
- LabStyle Innovations
- NOWDiagnostics Company
- OraSure Technologies
- Roche Diagnostics
- SD Biosensor
- Sinocare
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 38: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: USA 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 41: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: USA 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
CANADA
- Table 44: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 47: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
JAPAN
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 50: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 53: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
CHINA
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 56: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: China 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 59: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: China 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
EUROPE
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 62: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 63: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 64: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 65: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 67: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 68: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 70: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
FRANCE
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 71: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 73: France 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 74: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 76: France 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
GERMANY
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 77: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 79: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 80: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 82: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
ITALY
- Table 83: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 85: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 86: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 88: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 89: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 91: UK 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 92: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 94: UK 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 95: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 97: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 98: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 100: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 102: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 103: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
- Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 105: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 106: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AccuBioTech
- ACON Laboratories
- bioLytical Laboratories
- i-Health Lab
- LabStyle Innovations
- NOWDiagnostics Company
- OraSure Technologies
- Roche Diagnostics
- SD Biosensor
- Sinocare
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 19.4 Billion |
Forecasted Market Value ( USD | $ 39 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |